Detalhe da pesquisa
1.
STANDARD TREATMENT WITH BEVACIZUMAB AS TARGETED THERAPY IN CERVICAL CANCER.
Rev Invest Clin
; 72(4): 213-218, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064702
2.
Standard Treatment with Bevacizumab as Targeted Therapy in Cervical Cancer.
Rev Invest Clin
; 73(3)2020 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488224
3.
Standard treatment with bevacizumab as targeted therapy in cervical cancer
Rev. invest. clín
; 72(4): 213-218, Jul.-Aug. 2020.
Artigo
em Inglês
| LILACS | ID: biblio-1251858